For the Inventor, By the Inventor

Enter inventor name

Boston, MA, United States of America

Andreas Goutopoulos

USPTO Granted Patents = 50 (Patent Applications = 7)

CIPO Patents = 16 (Patent Applications = 9)

EPO Patents = 21 (Patent Applications = 30)

Average Co-Inventor Count = 5.5

ph-index = 7

Forward Citations = 170(Granted Patents)

Forward Citations (Not Self Cited) = 145(Dec 10, 2025)

Location History:

Storrs, CT (US) (2007)
Boston, MA (US) (2007 - 2021)

Company Filing History:

35 out of 2,943

Merck Patent Gmbh

Merck Serono S. A.

University of Connecticut

Years Active: 2007-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

ACSS2 Inhibitors

BTK Inhibitors

IRAK Inhibitors

Pyrimidine Compounds

Neurodegenerative Diseases

Kinase Activity Modulators

Cancer Treatment

Glycosidase Inhibitors

Macrocyclic Compounds

Amino Azaheterocyclic Carboxamides

Piperazine Derivatives

Cannabinoid Receptor Ligands

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441689 - ACSS2 inhibitors and methods of use thereof (2025-10-14),

2. 12133852 - ACSS2 inhibitors and methods of use thereof (2024-11-05),

3. 11098041 - Heteroaryl compounds as BTK inhibitors and uses thereof (2021-08-24),

4. 10851064 - ACSS2 inhibitors and methods of use thereof (2020-12-01),

5. 10517872 - Pyridazinone macrocycles as IRAK inhibitors and uses thereof (2019-12-31),

6. 10413562 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity (2019-09-17),

7. 10253023 - Heteroaryl compounds as BTK inhibitors and uses thereof (2019-04-09),

8. 10233160 - Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors (2019-03-19),

9. 10016448 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity (2018-07-10),

10. 9981925 - Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors (2018-05-29),

11. 9938262 - Benzamides (2018-04-10),

12. 9931324 - Indolizine derivatives and their use in neurodegenerative diseases (2018-04-03),

13. 9867826 - Heterocycles as modulators of kinase activity (2018-01-16),

14. 9815836 - Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof (2017-11-14),

15. 9775830 - Dihydropyrazoles (2017-10-03),

Title: The Innovative Journey of Andreas Goutopoulos

Introduction: Andreas Goutopoulos is a renowned inventor based in Boston, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Andreas Goutopoulos holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Andreas Goutopoulos has worked with leading tech companies, research institutions, and universities, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Andreas Goutopoulos has collaborated with top engineers, scientists, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Andreas Goutopoulos continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of turning ideas into reality.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…